
LEM Surgical wins new FDA clearance for humanoid surgical robot
LEM Surgical announced today that the FDA granted a new 510(k) clearance for its Dynamis robotic surgical system.

LEM Surgical announced today that the FDA granted a new 510(k) clearance for its Dynamis robotic surgical system.

Researchers at The University of Alabama in Huntsville (UAH), a part of The University of Alabama System, have published new findings suggesting continuous low-intensity ultrasound may help shift the body’s immune response from prolonged inflammation toward tissue repair, a discovery that could eventually contribute to novel treatments for joint injuries and post-traumatic osteoarthritis.

The largest and longest clinical trial of its kind has found that resurfacing the kneecap during total knee replacement is likely to be the most cost-effective approach for patients and health care systems over the long term.

Distalmotion announced today that it received FDA 510(k) clearance for its Dexter surgical robot in a range of gynecology procedures.

Embolization of abnormal blood vessels using rapidly resorbable gelatin-based microspheres is safe and provides significant, lasting pain relief and functional improvement for patients with osteoarthritis-related knee pain, according to a new study published in Radiology.

SurGenTec announced today that the FDA cleared its ION-L lumbar facet fixation system for degenerative disc disease (DDD).

The planned trial is expected to include 300 participants across two treatment arms.

Designed for spinal fusion surgery, Lux is designed to increase the chances of procedural success and provide greater flexibility once implants are fitted.
The procedure is comparable to hip and knee replacement surgeries, where a prosthetic implant is used to replace damaged joint surfaces

Published today in Cell, the team applied machine learning to blood plasma protein data from more than 48,000 UK Biobank participants, using matched cancer registry records to identify those who later developed lung cancer.